WEBSITECHANGES

Website Changes

---

04/30/2020

Pharmacokinetics, Safety and Tolerability of Olaparib and Temozolomide for Recurrent Glioblastoma: Results of the Phase I OPARATIC Trial

---

04/30/2020

UNIQUE GREETING CARDS TAKE ON NEW MEANING IN THE ERA OF COVID-19

---

04/29/2020

Musella Foundation Webinar Series: This Sunday

---

04/27/2020

CT103 - Final results for OptimalTTF-1: Optimizing Tumor Treating Fields with targeted skull remodeling surgery for first recurrence glioblastoma: Phase 1 trial

---

04/27/2020

EF-19 - A post-approval registry study of TTFields for the treatment of recurrent glioblastoma (GBM)

---

04/27/2020

CBD Shows Promise For Fighting Aggressive Brain Cancer

---

04/25/2020

A Phase II Randomized, Multicenter, Open-Label Trial of Continuing Adjuvant Temozolomide Beyond Six Cycles in Patients With Glioblastoma (GEINO 14-01)

---

04/24/2020

Immunotherapies combine for triple threat against deadly brain cancer

---

04/23/2020

Reinforcement Learning for Optimal Scheduling of Glioblastoma Treatment With Temozolomide

---

04/23/2020

Surveys! We need your participation!

---

04/18/2020

NW Bio To Discuss Projected Schedule For Data Lock, Unblinding and Top Line Data From Its Phase 3 Clinical Trial At Annual Shareholder Meeting

---

04/17/2020

Lessons Learned in Using Laser Interstitial Thermal Therapy (LITT) for Treatment of Brain Tumors: A Case Series of 238 Patients From A Single Institution

---

04/10/2020

Musella Foundation Webinar Series: This Sunday 4/12/2020

---

04/10/2020

Prophylactic Anticonvulsant Therapy in High-Grade Glioma: A Systematic Review and Meta-Analysis of Longitudinal Studies

---

04/08/2020

Study Shows Possible Alternative Treatment for High-Grade Glioma Tumors in Infants

---

04/06/2020

Stereotactic Radiotherapy in Recurrent Glioblastoma: A Valid Salvage Treatment Option.

---

04/05/2020

Brain Tumor Patients and the COVID-19 Crisis! Live Webinar tonight (4/5/2020) 7pm Eastern Time

---

04/05/2020

Brain Tumor Patients and the COVID-19 Crisis

---

04/05/2020

Musella Foundation Copayment Assistance Program now open to New (and Renewal) Patients!

---

04/03/2020

MATEON THERAPEUTICS TEAM PUBLISHES A NEW PEER-REVIEWED ONCOLOGY ARTICLE ON THE POSITIVE CLINICAL STUDY RESULTS FOR OT-101 AGAINST RECALCITRANT RESISTANT ANAPLASTIC ASTROCYTOMA – A RARE FORM OF MALIGNANT BRAIN TUMOR

---

04/03/2020

Study: Niacin may help immune system battle a deadly brain tumor

---

04/02/2020

Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma.

---

04/02/2020

Phase I/II Clinical Study of ONC201 Begins in Japan

---

03/31/2020

UF brain tumor researcher embarks on first-in-human clinical trial of novel immunotherapy vaccine

---

03/30/2020

Musella Foundation Webinar Series

---